Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )
Completed · Phase 3 · Has a placebo group
Conditions studied: Chronic Lymphocytic Leukemia
In brief
The primary objective of this study is to evaluate the effect of the addition of idelalisib (formerly GS-1101) to bendamustine + rituximab (BR) on progression-free survival (PFS) in participants with previously treated chronic lymphocytic leukemia (CLL)
Key facts
- Study ID
- NCT01569295
- Run by
- Gilead Sciences
- People needed
- 416
- Starts
- 2012-06-15
- Expected to finish
- 2019-06-10
- Last updated by the study team
- 2020-03-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCLA Medical Center — Los Angeles, California, United States
- Stanford Cancer Center — Palo Alto, California, United States
- Rocky Mountain Cancer Center — Denver, Colorado, United States
- University of Florida — Gainesville, Florida, United States
- Winship Cancer Institute at Emory University — Atlanta, Georgia, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- Summit Medical Group, P.A. — Morristown, New Jersey, United States
- North Shore University Hospital — Manhasset, New York, United States
- Long Island Jewish Medical Center — New Hyde Park, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Columbia University Medical Center — New York, New York, United States
- Willamette Valley Cancer Center — Eugene, Oregon, United States
- Charleston Hematology Oncology — Charleston, South Carolina, United States
- Texas Oncology — Austin, Texas, United States
- Texas Oncology PA — Dallas, Texas, United States
- Texas Oncology — Fort Worth, Texas, United States
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States
- Seattle Cancer Care Alliance — Seattle, Washington, United States
- Cancer Care Northwest, US Oncology — Spokane, Washington, United States
- Virginia Cancer Specialists, PC — Vancouver, Washington, United States
- Medical College of Wisconsin — Milwaukee, Wisconsin, United States
- St Vincent's Hospital - Sydney — Darlinghurst, New South Wales, Australia
- Gosford Hospital — Gosford, New South Wales, Australia
- Clearview Cancer Institute — Huntsville, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.